Serum angiotensin-converting enzyme in sarcoidosis and other diseases

[Use of biological microchips in the determination of drug-resistance of Mycobacterium tuberculosis to rifampicin].

Problemy tuberkuleza i boleznei legkikh·2005

Expanding the boundaries of occupational therapy practice through student fieldwork experiences: description of a provincially-funded community development project.

Canadian journal of occupational therapy. Revue canadienne d'ergotherapie·2002

Knowing from whence we came: reflecting on return-to-work and interpersonal relationships.

Canadian journal of occupational therapy. Revue canadienne d'ergotherapie·2002

Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization.

Annals of surgical oncology·2001

Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001

The Caregiver Quality of Life Index-Cancer (CQOLC) scale: development and validation of an instrument to measure quality of life of the family caregiver of patients with cancer.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·1999

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet (London, England)·2026

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Lancet (London, England)·2026

Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial.

Lancet (London, England)·2026

Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030.

Lancet (London, England)·2026

Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.

Lancet (London, England)·2026